These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3218908)

  • 1. Significance of insulin receptors in the action of sulphonylurea drugs.
    Huupponen R
    Ann Clin Res; 1988; 20(5):373-9. PubMed ID: 3218908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphonylurea in combination with insulin therapy: does it make sense? A review.
    Kyllästinen M
    Ann Clin Res; 1983; 15 Suppl 37():29-32. PubMed ID: 6383182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.
    Kolterman OG; Olefsky JM
    Diabetes Care; 1984; 7 Suppl 1():81-8. PubMed ID: 6376033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
    De Vries CP; van der Veen EA
    Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of action of peroral antidiabetics. Sulfonylurea preparations block the ATP-dependent potassium channels].
    Larsson O; Kindmark H; Bränström R; Berggren PO
    Lakartidningen; 1997 Nov; 94(48):4473-7. PubMed ID: 9424548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular loci of sulfonylurea actions.
    Lebovitz HE
    Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sulphonylurea derivatives, SPC-703 and tolbutamide, on insulin binding by isolated rat adipocytes.
    Skowroński R; Madrala A; Angielski S
    Acta Biochim Pol; 1984; 31(2):251-62. PubMed ID: 6385586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonylurea effects on target tissues for insulin.
    McCaleb ML; Maloff BL; Nowak SM; Lockwood DH
    Diabetes Care; 1984; 7 Suppl 1():42-6. PubMed ID: 6376028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.
    Melander A; Bitzén PO; Faber O; Groop L
    Drugs; 1989 Jan; 37(1):58-72. PubMed ID: 2651086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of biguanides and sulfonylureas on insulin receptors in cultured cells.
    Goldfine ID; Iwamoto Y; Pezzino V; Trischitta V; Purrello F; Vigneri R
    Diabetes Care; 1984; 7 Suppl 1():54-8. PubMed ID: 6734405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets.
    Del Guerra S; Marselli L; Lupi R; Boggi U; Mosca F; Benzi L; Del Prato S; Marchetti P
    J Diabetes Complications; 2005; 19(1):60-4. PubMed ID: 15642492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphonylureas in vitro do not alter insulin binding or insulin effect on amino acid transport in rat hepatocytes.
    Dolais-Kitabgi J; Alengrin F; Freychet P
    Diabetologia; 1983 Jun; 24(6):441-4. PubMed ID: 6350080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diet and sulfonylurea drugs on insulin resistance and insulin-receptor function.
    Pi-Sunyer FX
    Curr Concepts Nutr; 1983; 12():111-27. PubMed ID: 6342969
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral antidiabetic agents: recent aspects].
    Keller U; Berger W
    Schweiz Med Wochenschr; 1983 Apr; 113(17):645-50. PubMed ID: 6191388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapancreatic action of sulphonylureas: effect of gliquidone on insulin and glucagon binding to rat liver plasma membranes.
    Bachmann W; Böttger I; Haslbeck M; Mehnert H
    Eur J Clin Invest; 1979 Dec; 9(6):411-5. PubMed ID: 119639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possible effect of bromocriptine on the insulin receptor].
    Jiménez-Mejías ME; Guerrero-Montávez JM; Aznar-Martín A
    Rev Esp Fisiol; 1984 Jun; 40(2):133-9. PubMed ID: 6385156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine does not influence insulin binding on circulating monocytes.
    De Pirro R; Tamburrano G; Fusco A; Lauro R
    Endokrinologie; 1980 Mar; 75(2):243-6. PubMed ID: 6995104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral sulphonylureas on blood glucose and insulin.
    Adadevoh BK; Bolodeoku JO
    Ghana Med J; 1973 Dec; 12(4):360-5. PubMed ID: 4282692
    [No Abstract]   [Full Text] [Related]  

  • 20. Are insulin receptors clinically significant?
    Seltzer HS
    J Lab Clin Med; 1982 Dec; 100(6):815-21. PubMed ID: 7142787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.